Objective-To assess the presence of human papillomavirus (HPV) DNA in urethral and urine specimens from men with and without sexually transmitted diseases. Design-Prospective study. Setting-Two London departments of genitourinary medicine Patients-100 men with urethral gonorrhoea, 31 men with penile warts and 37 men with genital dermatoses. Methods-Urethral and urine specimens were taken, HPV DNA extracted and then amplified using the polymerase chain reaction. HPV types 6, 11, 16, 18, 31 and 33 were identified using Southern blotting followed by hybridisation. Results-HPV DNA was detected in 18-31% of urethral swab specimens and in 0-14% of urine specimens. Men with penile warts had HPV detected in urethral swabs more often than did men in the other two clinical groups. "High risk" HPV types were found in 71-83% of swab specimens and in 73-80% of urine specimens containing HPV DNA. Conclusions-HPV is present in the urogenital tracts of men with gonorrhoea, penile warts and with genital dermatoses. In men with urethral gonorrhoea, detection of HPV in urethral specimens is not related to the number of sexual partners, condom usage, racial origin or past history of genital warts.
Introduction
Genital warts are the most common of the sexually transmitted viral diseases in the United Kingdom.' Evidence suggests23 that the majority of condylomata acuminata are sexually acquired, but the epidemiology of subclinical and latent infections of the genital tract with HPV is less well understood. 4 DNA from the "genitotropic" HPV types has been isolated from clinically normal cervices5 and it has been suggested6 that carriage of HPV in adjacent histologically normal tissue may be an important factor in the recurrence of disease after treatment. The male counterpart of carriage of HPV in the absence of disease has not been fully defined, but HPV DNA has been detected in the genital tracts of 5.8% of men with no evidence of condylomata acuminata attending blood donor and dermatology clinics.7
Men with urethral gonorrhoea form a well characterised group,8 whose lifestyles have put them at risk of acquiring sexually transmitted diseases. In an attempt to improve the rational basis for the counselling of such men, we evaluated the frequency of carriage of HPV DNA in their urethras and urine. The results were then compared with those obtained from studying a group of men with penile warts and a group of men with no evidence of sexually transmitted diseases.
Methods
Patients and collection of specimens One hundred male patients who attended consecutively one of two genitourinary medicine clinics during the period 1 July 1990 to 31 December 1990 were selected. Selection was on the basis of having symptoms or signs of urethritis, finding intracellular Gram-negative diplococci on the urethral smear, and no condylomata acuminata visible on clinical examination of the genitalia, including the meatus. A urethral sample taken with a 10,l plastic loop (GIBCO, Paisley, UK) was spread onto a glass slide for Gram staining and subsequently smeared onto a selective medium. Then, the plates were incubated at 37°C in an atmosphere of air and 6% CO2 before transport to the laboratory for further incubation and identification using standard methods. Men were excluded if Neisseria gonorrhoeae was found not to have been cultured from the urethral swab.
After informed consent had been given, a detailed clinical history was obtained using a structured questionnaire. A second urethral sample was taken using a cotton-tipped swab ("STD-Pen for Males", Abbott Laboratories, Chicago, Illinois, USA) from all of the men. This and the first sample from the two glass urine test were kept for subsequent analysis in 88 of the cases.
Urethral swab and urine samples were also taken in the same manner from 32 men who attended the clinics with penile warts and from 37 men presenting with genital der- nM TRIS-of HPV DNA were tested and the detection DTA-tetra limit was found consistently to be 10-'4g or illed water less of DNA. This corresponded to approxi-/ml), 28Rpl mately 10 molecules of HPV DNA/100 p1 of reaction mixture.
Southern blotting 20pl of each of the products of the PCR were analysed by using agarose gel electrophoresis with ethidium bromide staining. (oX174 DNA cut with Hae III restriction endonuclease was used to enable estimation of the sizes of the PCR products. Southern blotting was performed using a modification of standard protocols.'3 The agarose gel was denatured for 30 min in 1-5M NaCI/ 0-5M NaOH, followed by neutralisation for 60 min in 1-5M NaClI/05M Tris pH 7.5/lmM EDTA. The DNA products were then transferred from the agarose gel to nylon membranes (GeneScreen Plus, DuPont, USA) by a capillary blot procedure using 6 x SSC (0.9M NaCl, 0-09M sodium citrate) as the transfer buffer. Hydridisation for the detection of HPV types 6, 11, 16, 18, 31 and 33 was performed at 55°C for 16 to 24 hours using oligonucleotide probes which had been end-labelled In contrast, samples obtained by applying abrasive pads and brushes to the male genitalia'9 32 have enabled specific detection of HPV. The majority of urethral condylomata acuminata develop in the distal 1 cm of the urethra33 and it has been postulated32 that this area of the urethra may be analogous to the transitional zone of the cervical epithelium and might act as a reservoir for infection with HPV.22 In view of these observations, the finding'9 that urethral swabs are as effective as abrasive pads in detecting infection with HPV in male genitalia, and that the men had a urethral discharge, we undertook urethral sampling of our patients. Cotton wool-tipped swabs, designed originally for the detection of C. trachomatis, were used, as they have been found previously to be acceptable to patients and effective in sampling the urethral epithelium for urogenital pathogens. As several groups"' 3435 have detected HPV DNA in urine, examination of urine also formed part of our study.
The PCR, when used under carefully controlled conditions, is currently the most sensitive technique for the detection of HPV,36 allowing detection of very few viral particles. Sample size, therefore, may be small and genital trauma minimised. As great care was taken during the collection of clinical material, and both positive and negative controls were used at all stages of analysis of the specimens, we are confident that the results reflect the true occurrence of HPV in the specimens, rather than contamination. In an attempt to assess the significance of finding HPV in a proportion of the urethral swab specimens from men with gonorrhoea, we investigated two other groups of men from the same clinics. Men with penile warts were included in view of their clinically apparent infection with HPV and because of evidence38 suggesting that HPV may be found contaminating the urethra as a result of passive transfer from adjacent warts. We also included a group of men with no sexually transmitted disease at the time of sampling, that is, those with genital dermatoses. Of particular note is the observation that similar proportions of men with gonorrhoea and men with no sexually transmitted disease had HPV DNA detected in both their urethral swab and urine specimens. Furthermore, this observation suggests that urethral irritation per se in men with gonorrhoea is not a significant factor in the shedding of HPV from the urethra. The small number of urine specimens taken from men with penile warts makes interpretation of the results for this group of men difficult.
The detection of HPV DNA in the urine of 0-14% of the men in our study contrasts with that in the urine of 15 (88%) of 17 men with meatal warts and none of 14 healthy controls in one study," and with that in the urine of two (22%) of 9 men whose partners had HPV infection.'4 Condylomata acuminata occur rarely in the bladder39 and there have been conflicting reports of HPV DNA in the prostate.40 41 As only a small proportion of men in each clinical group had HPV DNA detectable in both the urine and urethral swab specimens, it may be that these different sampling techniques enable results in assessment of different aspects of infection of the urogenital tract with HPV.
The significance of detecting HPVs in the male urogenital tract is difficult to determine. It is possible that a few viral particles might remain on the genitalia from recent sexual contact, and even from underwear,42 without actually representing active infection. The natural history of subclinical HPV infection and, in particular the infectiousness for sexual partners, is also unknown. Indeed, it is currently unclear whether subclinical HPV infection is sexually acquired43 as DNA of the genitotropic HPV types has been found in virgins,'43 the foreskin of neonates44 and on fomites. 45 The lack of correlation between the presence of HPV DNA and the number of life-time sexual partners of the men seen in our study argues against sexual transmission, as does the reported condom usage, although the reliability of such reported behaviour is clearly open to question. Furthermore, the minor differences that we detected in the rates of HPV infection in men with and without sexually transmitted diseases suggest that sexual lifestyle may not be a major factor in determining infection with HPV. However, the greater incidence of HPV in men in younger age groups is consistent with sexual transmission. Other authors2437 have also found ambiguous evidence of sexual transmission in clinically inapparent infections.
Our finding of a larger proportion of "high risk" HPV types than "low risk" types in asymptomatic infections normally found in condylomata acuminata, is consistent with the results of other studies.242637 Furthermore, our observations were independent of both the sample type and patient group, and may be relevant to the concept of the "high risk male", whose sexual partner(s) are at increased risk of cervical dysplasia.4647 In view of the evidence linking infection with HPV to anogenital neoplasia in both women and men,48 further work needs to be done to fully evaluate the various methods for detecting HPV infection. In particular, the role of sexual activity in the acquisition and maintenance of genital HPV infection needs to be clarified. Only then will it be possible to understand the nature of this condition, and to develop rational management strategies. 
